FRANKENFIELD CHRISTOPHER JAMES (Chief Operating Officer) sold 22.1% of their position (7.03K shares) of XILIO THERAPEUTICS, INC. on the open market
Open‑market sale worth $4.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/5/2026ACC: 0001193125-26-002517
Officer· Chief Operating Officer
Since Aug 2023
+661.76K
Net shares
Net buyer
$4.5K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
688.16K acquired · 26.41K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+19.38K
Price / share
—
Trade value
—
% of position
156.0%
1/1/2026
12.42K→31.80K
Common Stock
Direct
Shares
−7.03K
Price / share
$0.64
Trade value
$4.52K
% of position
22.1%
1/2/2026
31.80K→24.77K
Total
Net shares
+12.35K
Net value
-$4.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2026 | M · Option Exercise | +19.38K | — | — | 156.0% | 12.42K | 31.80K |
| Common Stock Direct | 1/2/2026 | S · Sale | −7.03K | $0.64 | $4.52K | 22.1% | 31.80K | 24.77K |
| Total | +12.35K | -$4.52K | ||||||
Derivative Transactions2
Stock Option (right to buy)
Direct
Converts to
Common Stock
668.79K shares
Shares
+668.79K
Strike price
0.841
Held after
668.79K
Exercisable
—
12/31/2025
Restricted Stock Units
Direct
Converts to
Common Stock
19.38K shares
Shares
−19.38K
Strike price
Held after
38.75K
Exercisable
—
1/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock668.79K shares | 12/31/2025 | A · Award | +668.79K | 0.841 | — | 668.79K |
| Restricted Stock Units Direct | Common Stock19.38K shares | 1/1/2026 | M · Option Exercise | −19.38K | — | 38.75K |